“Evaluation of 1,5-Anhydroglucitol As a Biomarker for Type 2 Diabetes Mellitus in Patients Without Overt Nephropathy”. Brazilian Journal of Pharmaceutical Sciences, vol. 57, novembro de 2022, https://doi.org/10.1590/s2175-97902020000419078.